Extravasation of an antibody‐drug conjugate: A case report of epidermal necrosis after trastuzumab‐emtansine extravasation

WHAT IS KNOWN AND OBJECTIVE: Trastuzumab‐emtansine is an antibody‐drug conjugate developed to decrease off‐target toxicity. According to the product label, reactions secondary to extravasation are mild or moderate. CASE SUMMARY: We report on a 51‐year‐old woman who developed epidermal necrosis after...

Descripción completa

Detalles Bibliográficos
Autores principales: Sallevelt, Bastiaan T. G. M., Teunis, Teun, Agterof, Mariette J., van den Broek, Marcel P. H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383643/
https://www.ncbi.nlm.nih.gov/pubmed/32412114
http://dx.doi.org/10.1111/jcpt.13148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7383643/
https://www.ncbi.nlm.nih.gov/pubmed/32412114
http://dx.doi.org/10.1111/jcpt.13148

Ejemplares similares